ABL Tyrosine Kinase Inhibition Variable Effects on the Invasive Properties of Different Triple Negative Breast Cancer Cell Lines

The non-receptor tyrosine kinase ABL drives myeloid progenitor expansion in human chronic myeloid leukemia. ABL inhibition by the tyrosine kinase inhibitor nilotinib is a first-line treatment for this disease. Recently, ABL has also been implicated in the transforming properties of solid tumors, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevalier, Clément, Cannet, Aude, Descamps, Simon, Sirvent, Audrey, Simon, Valérie, Roche, Serge, Benistant, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372365/
https://www.ncbi.nlm.nih.gov/pubmed/25803821
http://dx.doi.org/10.1371/journal.pone.0118854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372365/
https://www.ncbi.nlm.nih.gov/pubmed/25803821
http://dx.doi.org/10.1371/journal.pone.0118854

Ejemplares similares